Literature DB >> 8554480

Improved arousal and initiation following tricyclic antidepressant use in severe brain injury.

D L Reinhard1, J Whyte, M E Sandel.   

Abstract

Three patients with severe traumatic brain injury demonstrated significant improvement in arousal and initiation after administration of tricyclic antidepressants. The first patient showed improved motor and speech initiation in response to amitriptyline following several months of functional plateau. The second patient was minimally responsive 2 months after injury and demonstrated improved arousal following the use of desipramine. Both patients deteriorated when the medications were discontinued and improved again when they were restarted. These two cases provide strong evidence for a medication effect. The third patient began to verbalize following desipramine administration, despite being mute for more than a year after injury. Previous case reports describe cognitive-enhancing effects, such as improved arousal, attention, memory, and initiation, of dopaminergic agents, and in the case of tricyclic antidepressants, effects on agitation. The role of norepinephrine in promoting neurological recovery after brain lesions has been demonstrated in animals. The cases presented here provide some of the first data to show similar efficacy in humans and underscore the need for controlled trials to better determine which patients will benefit.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8554480     DOI: 10.1016/s0003-9993(96)90225-7

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  6 in total

Review 1.  Pharmacotherapy for disorders of consciousness: are 'awakening' drugs really a possibility?

Authors:  Rosella Ciurleo; Placido Bramanti; Rocco Salvatore Calabrò
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

Review 2.  Awakenings and awareness recovery in disorders of consciousness: is there a role for drugs?

Authors:  Francesca Pistoia; Elisa Mura; Stefano Govoni; Massimo Fini; Marco Sarà
Journal:  CNS Drugs       Date:  2010-08       Impact factor: 5.749

3.  MicroRNA alteration in cerebrospinal fluid from comatose patients with traumatic brain injury after right median nerve stimulation.

Authors:  Ying Jia; Yi-Fan He; Ye Tian; Yuan-Zhi Wang; Rui-Ting Zhao; Xiao-Chun Li; Jian Sun; Ying-Sheng Wei; Shuo An; Heng-Jie Yuan; Chun-Xiao Wan; Rong-Cai Jiang
Journal:  Exp Brain Res       Date:  2022-08-07       Impact factor: 2.064

4.  Emerging Treatments for Disorders of Consciousness in Paediatric Age.

Authors:  Hassna Irzan; Marco Pozzi; Nino Chikhladze; Serghei Cebanu; Artashes Tadevosyan; Cornelia Calcii; Alexander Tsiskaridze; Andrew Melbourne; Sandra Strazzer; Marc Modat; Erika Molteni
Journal:  Brain Sci       Date:  2022-01-31

Review 5.  Selective Serotonin Reuptake Inhibitors for Treating Neurocognitive and Neuropsychiatric Disorders Following Traumatic Brain Injury: An Evaluation of Current Evidence.

Authors:  John K Yue; John F Burke; Pavan S Upadhyayula; Ethan A Winkler; Hansen Deng; Caitlin K Robinson; Romain Pirracchio; Catherine G Suen; Sourabh Sharma; Adam R Ferguson; Laura B Ngwenya; Murray B Stein; Geoffrey T Manley; Phiroz E Tarapore
Journal:  Brain Sci       Date:  2017-07-25

6.  Therapies to Restore Consciousness in Patients with Severe Brain Injuries: A Gap Analysis and Future Directions.

Authors:  Brian L Edlow; Leandro R D Sanz; Robert D Stevens; Olivia Gosseries; Len Polizzotto; Nader Pouratian; John D Rolston; Samuel B Snider; Aurore Thibaut
Journal:  Neurocrit Care       Date:  2021-07-08       Impact factor: 3.210

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.